Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 8Breast 8Gastrointestinal 7Tumor-Agnostic 6Thoracic 3Lymphoid 3Gynecologic 3Other 2Dermatologic 2CNS 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1

Conditions

Obesity 1Non-alcoholic Fatty Liver Disease 1Multiple Myeloma 1Metabolic Syndrome 1Liver Cirrhosis 1Dyspnea 1Colorectal Neoplasms 1Cardiotoxicity 1

Interventions

Surveys and Questionnaires 9Blood Specimen Collection 5naloxegol 3Therapeutics 3Observation 3Interviews as Topic 3Bariatric Surgery 3naldemedine 2exemestane 2Tirzepatide 2Tamoxifen 2Psychiatric Rehabilitation 2Paclitaxel 2Hematologic Tests 2Esophagectomy 2Echocardiography 2Carboplatin 2Biopsy 2BaseLine dental cement 2Anastrozole 2trametinib 1sotorasib 1semaglutide 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hematologic Tests × Other × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

NCT03663062 2020-11-04

OSCAR

South Tyneside and Sunderland NHS Foundation Trust

Completed
1,430 enrolled
GastrointestinalOther

Liver Cirrhosis, Obesity, Colorectal Neoplasms, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡